128 related articles for article (PubMed ID: 34995562)
1. Disparities in Cancer Specific and Overall Survival Outcomes in African Americans With Renal Cell Carcinoma: Analysis From the International Marker Consortium for Renal Cancer (INMARC).
Meagher MF; Patil D; Saito K; Javier-Desloges JF; Bradshaw AW; Patel SH; Cotta BH; Yasuda Y; Eldefrawy A; Ghali F; Nasseri R; Wan F; Fujii Y; Master V; Derweesh IH
Urology; 2022 May; 163():164-176. PubMed ID: 34995562
[TBL] [Abstract][Full Text] [Related]
2. Elevated preoperative C-reactive protein is associated with renal functional decline and non-cancer mortality in surgically treated renal cell carcinoma: analysis from the INternational Marker Consortium for Renal Cancer (INMARC).
Cotta BH; Meagher MF; Patil D; Saito K; Patel SH; Patel DN; Miller N; Dutt R; Keiner C; Bradshaw AW; Wan F; Eldefrawy A; Yasuda Y; Fujii Y; Master V; Derweesh IH
BJU Int; 2021 Mar; 127(3):311-317. PubMed ID: 32772468
[TBL] [Abstract][Full Text] [Related]
3. Oncologic and Functional Outcomes of Radical and Partial Nephrectomy in pT3a Pathologically Upstaged Renal Cell Carcinoma: A Multi-institutional Analysis.
Patel SH; Uzzo RG; Larcher A; Peyronnet B; Lane BR; Pruthi D; Reddy M; Capitanio U; Joshi S; Noyes S; Eldefrawy A; Ghali F; Meagher MF; Hamilton ZA; Yim K; Nasseri R; Bradshaw AW; Dey S; Kirmiz S; Wan F; Liss MA; Bensalah K; Montorsi F; Derweesh IH
Clin Genitourin Cancer; 2020 Dec; 18(6):e723-e729. PubMed ID: 32600941
[TBL] [Abstract][Full Text] [Related]
4. Racial Comparison of Patients Undergoing Minimally Invasive Partial Nephrectomy for Renal Masses at a Large Volume Tertiary Center.
Sands KG; Bhatt R; Vetter J; Paradis A; Chow AK; Bhayani S; Figenshau RS; Venkatesh R
J Endourol; 2021 Sep; 35(9):1365-1371. PubMed ID: 33730861
[No Abstract] [Full Text] [Related]
5. Association of Elevated C-Reactive Protein with Worsened Outcomes in Different Histologies of Renal Cortical Tumors: Analysis of the INMARC Registry.
Saitta C; Afari JA; Patil D; Tanaka H; Yuen KL; Wang L; Cortes J; Liu F; Mahmood M; Matian J; Mansour M; Puri D; Cerrato C; Nguyen MV; Hakimi K; Kobayashi M; Fukuda S; Meagher MF; Fujii Y; Master V; Derweesh IH
Clin Genitourin Cancer; 2024 Jun; 22(3):102098. PubMed ID: 38733897
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological characteristics and outcomes of surgically excised renal masses in African Americans.
Qi P; Tsivian M; Abern MR; Passoni NM; McGinley KF; Polascik TJ
Urol Oncol; 2014 Jul; 32(5):555-60. PubMed ID: 24495445
[TBL] [Abstract][Full Text] [Related]
7. Robotic partial nephrectomy vs minimally invasive radical nephrectomy for clinical T2a renal mass: a propensity score-matched comparison from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group.
Bradshaw AW; Autorino R; Simone G; Yang B; Uzzo RG; Porpiglia F; Capitanio U; Porter J; Bertolo R; Minervini A; Lau C; Jacobsohn K; Ashrafi A; Eun D; Mottrie A; White WM; Schips L; Challacombe BJ; De Cobelli O; Mir CM; Veccia A; Larcher A; Kutikov A; Aron M; Dasgupta P; Montorsi F; Gill IS; Sundaram CP; Kaouk J; Derweesh IH
BJU Int; 2020 Jul; 126(1):114-123. PubMed ID: 32232920
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors for recurrence and outcomes in T1a renal cell carcinoma: Analysis of the INMARC (International Marker Consortium for Renal Cancer) database.
Liu F; Wang L; Meagher MF; Afari J; Saitta C; Dhanji S; Ghassemzadeh S; Shah A; Puri D; Nguyen MV; Hakimi K; Schmeusser B; Greenwald R; Medline A; Kamal F; Ali A; Fukuda S; Kobayashi M; Chen W; Fan B; Aida Y; Maezawa Y; Asai S; Tanaka H; Patil D; Fujii Y; Master V; Derweesh IH
Urol Oncol; 2024 Jun; ():. PubMed ID: 38926077
[TBL] [Abstract][Full Text] [Related]
9. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.
Nguyen DP; Vertosick EA; Corradi RB; Vilaseca A; Benfante NE; Touijer KA; Sjoberg DD; Russo P
Urol Oncol; 2016 Jun; 34(6):259.e1-8. PubMed ID: 26947350
[TBL] [Abstract][Full Text] [Related]
10. Cancer control of partial nephrectomy for high-risk localized renal cell carcinoma: population-based and single-institutional analysis.
O'Malley RL; Hayn MH; Brewer KA; Underwood W; Hellenthal NJ; Kim HL; Sorokin I; Schwaab T
World J Urol; 2015 Nov; 33(11):1807-14. PubMed ID: 25805189
[TBL] [Abstract][Full Text] [Related]
11. Should patients with low-risk renal cell carcinoma be followed differently after nephron-sparing surgery vs radical nephrectomy?
Abu-Ghanem Y; Powles T; Capitanio U; Beisland C; Järvinen P; Stewart GD; Gudmundsson E; Lam TBL; Marconi L; Fernandéz-Pello S; Nisen H; Meijer RP; Volpe A; Ljungberg B; Klatte T; Bensalah K; Dabestani S; Bex A
BJU Int; 2021 Sep; 128(3):386-394. PubMed ID: 33794055
[TBL] [Abstract][Full Text] [Related]
12. Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.
Simone G; Tuderti G; Anceschi U; Papalia R; Ferriero M; Misuraca L; Minisola F; Mastroianni R; Costantini M; Guaglianone S; Sentinelli S; Gallucci M
World J Urol; 2017 May; 35(5):789-794. PubMed ID: 27578234
[TBL] [Abstract][Full Text] [Related]
13. Female Gender Predicts Favorable Prognosis in Patients With Non-metastatic Clear Cell Renal Cell Carcinoma Undergoing Curative Surgery: Results From the International Marker Consortium for Renal Cancer (INMARC).
Fukushima H; Saito K; Yasuda Y; Tanaka H; Patil D; Cotta BH; Patel SH; Master VA; Derweesh IH; Fujii Y
Clin Genitourin Cancer; 2020 Apr; 18(2):111-116.e1. PubMed ID: 32001181
[TBL] [Abstract][Full Text] [Related]
14. Racial Disparities in Histology and Short-Term Renal Functional Outcomes Following Robotic Nephron-Sparing Surgery.
Wang JC; Lai WR; Traore EJ; Liu J; Sholl AB; Mandava SH; Maddox MM; Mitchell GC; Viriyasiripong S; Silberstein JL; Kittles R; Lee BR
Clin Genitourin Cancer; 2017 Apr; 15(2):203-206. PubMed ID: 27554583
[TBL] [Abstract][Full Text] [Related]
15. Partial nephrectomy is not associated with an overall survival advantage over radical nephrectomy in elderly patients with stage Ib-II renal masses: An analysis of the national cancer data base.
Ristau BT; Handorf EA; Cahn DB; Kutikov A; Uzzo RG; Smaldone MC
Cancer; 2018 Oct; 124(19):3839-3848. PubMed ID: 30207380
[TBL] [Abstract][Full Text] [Related]
16. Association of race and margin status among patients undergoing robotic partial nephrectomy for T1 renal cell carcinoma: Results from a population-based cohort.
Chen VS; Abouassaly R; Gonzalez CM; Kutikov A; Smaldone MC; Meropol NJ; Psutka SP; Williams SB; O'Malley R; Sedlacek HM; Kim SP
Urol Oncol; 2017 Nov; 35(11):662.e17-662.e21. PubMed ID: 28781110
[TBL] [Abstract][Full Text] [Related]
17. Preoperative Elevation of C-Reactive Protein Is a Predictor for Adverse Oncologic Survival Outcomes for Renal Cell Carcinoma: Analysis from the International Marker Consortium Renal Cancer (INMARC).
Patel SH; Derweesh IH; Saito K; Patil D; Meagher MF; Bindayi A; Eldefrawy A; Patel DN; Nasseri R; Yasuda Y; Fujii Y; Master VA
Clin Genitourin Cancer; 2021 Aug; 19(4):e206-e215. PubMed ID: 33773937
[TBL] [Abstract][Full Text] [Related]
18. Racial disparities in survival among patients with advanced renal cell carcinoma in the targeted therapy era.
Rose TL; Deal AM; Krishnan B; Nielsen ME; Smith AB; Kim WY; Milowsky MI
Cancer; 2016 Oct; 122(19):2988-95. PubMed ID: 27341404
[TBL] [Abstract][Full Text] [Related]
19. Does the Unexpected Presence of Non-organ-confined Disease at Final Pathology Undermine Cancer Control in Patients with Clinical T1N0M0 Renal Cell Carcinoma Who Underwent Partial Nephrectomy?
Capitanio U; Stewart GD; Klatte T; Akdogan B; Roscigno M; Marszalek M; Dell'Oglio P; Zaffuto E; Rodriguez Faba O; Salagierski M; Lingard J; Carini M; Ouzaid I; Mir MC; Montorsi F; Da Pozzo LF; Stief C; Minervini A; Brookman-May SD
Eur Urol Focus; 2018 Dec; 4(6):972-977. PubMed ID: 28753867
[TBL] [Abstract][Full Text] [Related]
20. A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma.
Bianchi M; Gandaglia G; Trinh QD; Hansen J; Becker A; Abdollah F; Tian Z; Lughezzani G; Roghmann F; Briganti A; Montorsi F; Karakiewicz PI; Sun M
Urol Oncol; 2014 Jan; 32(1):46.e1-7. PubMed ID: 24054864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
